Fig. 1 · Structure
Documents & Downloads
Efruxifermin
Fc-FGF21 Fusion Protein
Efruxifermin is an Fc-FGF21 fusion protein comprising a human IgG1 Fc domain linked to a modified human FGF21. This compound exhibits a prolonged half-life and increased receptor affinity relative to native human FGF21. Efruxifermin is primarily utilized in research focused on non-alcoholic steatohepatitis, providing insights into metabolic regulation and potential therapeutic interventions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 2375240-92-7 |
| Applications | Fc-FGF21 Fusion Protein |
| Molecular Weight | 91.863 kDa |
| Synonyms | AKR-001; AMG-876 |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.